Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial therapy for bacterial and nonbacterial prostatitis.

Jackson E Fowler1

  • 1Division of Urology, University of Mississippi School of Medicine, Jackson, Mississippi, USA. jfowler@surgery.umsmed.edu

Urology
|January 11, 2003
PubMed
Summary

Antimicrobial therapy effectively treats chronic bacterial prostatitis, curing 70% of cases. For persistent infections, suppressive therapy with antibiotics like trimethoprim-sulfamethoxazole offers symptom relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies.

Current urology reports·2008
Same author

Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

The journal of pain·2006
Same author

How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?

The Journal of urology·2006
Same author

Renal cell carcinoma and end stage renal disease.

The Journal of urology·2006
Same author

Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.

Urology·2006
Same author

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

Annals of internal medicine·2004

Area of Science:

  • Urology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic bacterial prostatitis requires effective antimicrobial treatment.
  • Nonbacterial prostatitis has a different treatment paradigm.
  • Antibiotic therapy is the cornerstone for bacterial prostatitis.

Purpose of the Study:

  • To outline the role of antimicrobial therapy in chronic bacterial prostatitis.
  • To discuss treatment outcomes and alternative strategies for prostatitis management.

Main Methods:

  • Review of current antimicrobial treatment protocols for chronic bacterial prostatitis.
  • Analysis of treatment efficacy for fluoroquinolone antibiotics.
  • Evaluation of suppressive antimicrobial therapy for refractory cases.

Related Experiment Videos

Main Results:

  • Fluoroquinolone antibiotics achieve a cure rate of approximately 70% for chronic bacterial prostatitis within 2 to 4 weeks.
  • Suppressive antimicrobial therapy can effectively manage symptomatic manifestations when initial treatment fails.

Conclusions:

  • Antimicrobial therapy is crucial for bacterial prostatitis, with fluoroquinolones showing significant efficacy.
  • For treatment failures, suppressive therapy provides a viable option for symptom control in chronic prostatitis.